Patient access schemes

Interferon beta and glatiramer acetate are cost-effective treatments for multiple sclerosis

Treatment with interferon beta or glatiramer acetate reduces disability progression by 24-40% in patients with relapsing-remitting multiple sclerosis, according to a new study.…

More UK patients will now be eligible for two costly hepatitis C treatments

Sofosbuvir has received the green light from NICE but will not be available to patients until August 2015, while simeprevir will only be accessible through a patient access scheme.…

Wales will not have a Cancer Drugs Fund, health minister says

Wales will not have a Cancer Drugs Fund, despite a 98,000-signature petition calling for equity of access to cancer drugs for patients in England and Wales being handed to the Welsh Assembly on 5 November 2014.…

A report into the uptake of patient access schemes in the NHS

This article aims to assess the impact of the introduction of patient access schemes for cancer medicines on front-line NHS staff.…